Loading financial statements…
Import this data to Google Sheets with:
=jivedata("LGIH","financials")Full statements spill as a table. For one cell: =jivedata("LGIH","Revenue") or =jivedata("LGIH","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.
LGIH • CIK 0001580670
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Revenues | $2,358,580 | $2,202,598 | $1,705,504 | $1,719,523 |
| Cost of Goods and Services Sold | $1,816,393 | $1,669,310 | $1,351,958 | $1,387,473 |
| Selling Expense | $191,582 | $199,950 | $162,149 | $155,007 |
| General and Administrative Expense | $117,350 | $121,192 | $111,621 | $107,450 |
| Operating Income (Loss) | $233,255 | $212,146 | $79,776 | $79,025 |
| Other Nonoperating Income | $28,499 | $46,767 | $18,710 | $22,039 |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | $261,754 | $258,913 | $98,486 | $91,632 |
| Income Tax Expense (Benefit) | $62,527 | $62,842 | $25,934 | $25,463 |
| Net Income (Loss) Attributable to Parent | $199,227 | $196,071 | $72,552 | $66,169 |
| Weighted Average Number of Shares Outstanding, Basic | 23,507,136 | 23,529,724 | 23,188,965 | 23,071,842 |
| Weighted Average Number of Shares Outstanding, Diluted | 23,648,548 | 23,610,457 | 23,254,595 | 23,137,684 |
| Incremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares | 141,412 | 80,733 | 65,630 | 65,842 |
| Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | 11,412 | 46,146 | 47,436 | 60,718 |
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $48,978 | $53,197 | $61,247 | $61,081 |
| Accounts Receivable, after Allowance for Credit Loss | $41,319 | $28,717 | $32,467 | $33,850 |
| Inventory, Real Estate | $3,107,648 | $3,387,853 | $3,520,563 | $3,512,613 |
| Earnest Money Deposits | $30,354 | $36,049 | $28,950 | $19,248 |
| Property, Plant and Equipment, Net | $45,522 | $57,038 | $107,145 | $149,579 |
| Other Assets | $113,849 | $174,391 | $154,948 | $119,812 |
| Deferred Income Tax Assets, Net | $8,163 | $9,271 | $9,904 | $10,392 |
| Goodwill | $12,000 | $12,000 | $12,018 | $12,018 |
| Assets | $3,407,851 | $3,758,534 | $3,927,242 | $3,918,593 |
| Accounts Payable | $31,616 | $33,271 | $16,179 | $58,750 |
| Accrued Liabilities and Other Liabilities | $271,872 | $207,317 | $157,971 | $146,280 |
| Notes Payable | $1,248,332 | $1,480,718 | $1,656,803 | $1,580,907 |
| Liabilities | $1,551,820 | $1,721,306 | $1,830,953 | $1,785,937 |
| Common Stock, Value, Issued | $275 | $276 | $277 | $279 |
| Additional Paid in Capital | $321,062 | $337,161 | $347,308 | $354,476 |
| Retained Earnings (Accumulated Deficit) | $1,889,716 | $2,085,787 | $2,158,339 | $2,187,483 |
| Treasury Stock, Value | $355,022 | $385,996 | $409,635 | $409,582 |
| Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | $1,856,031 | $2,037,228 | $2,096,289 | $2,132,656 |
| Common Stock, Shares Authorized | 250,000,000 | 250,000,000 | 250,000,000 | 250,000,000 |
| Common Stock, Shares, Issued | 27,521,120 | 27,644,413 | 27,789,678 | 27,904,864 |
| Common Stock, Shares, Outstanding | 23,581,648 | 23,397,074 | 23,133,086 | 23,248,272 |
| Treasury Stock, Common, Shares | 3,939,472 | 4,247,339 | 4,656,592 | 4,656,592 |
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Net Income (Loss) Attributable to Parent | $199,227 | $196,071 | $72,552 | $66,169 |
| Net Cash Provided by (Used in) Operating Activities | $-56,968 | $-143,739 | $-139,973 | $132,558 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | $16,980 | $4,219 | $8,050 | $1,521 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $48,978 | $53,197 | $61,247 | $64,507 |
| Income (Loss) from Equity Method Investments | $12,834 | $13,302 | $1,928 | $2,840 |
| Payments to Acquire Property, Plant, and Equipment | — | — | $924 | $1,551 |
| Proceeds from Equity Method Investment, Distribution | $14,825 | $14,372 | $4,801 | $1,931 |
| Proceeds from Sale of Property, Plant, and Equipment | — | $25,441 | $24,700 | $53,103 |
| Depreciation, Depletion and Amortization | $2,408 | $3,108 | $4,322 | $4,968 |
| Payments to Acquire Equity Method Investments | $17,889 | $7,869 | $4,451 | $2,902 |
| Gain (Loss) on Disposition of Assets | $1,634 | $14,013 | $2,598 | $10,393 |
| Proceeds from Equity Method Investment, Distribution, Return of Capital | $5,684 | $0 | $8,613 | $2,739 |
| Share-based Payment Arrangement, Noncash Expense | $8,926 | $10,483 | $6,001 | $6,217 |
| Net Cash Provided by (Used in) Investing Activities | $-13,648 | $15,620 | $27,938 | $51,389 |
| Inventory Write-down | — | — | $6,717 | $11,398 |
| Increase (Decrease) in Deferred Income Taxes | $1,977 | $1,108 | $633 | $-41 |
| Increase (Decrease) in Accounts Receivable | $16,176 | $-12,602 | $3,750 | $-746 |
| Proceeds from Notes Payable | $887,283 | $992,313 | $668,695 | $421,367 |
| Increase (Decrease) in Inventories | $255,518 | $365,889 | $257,041 | $-9,848 |
| Repayments of Notes Payable | $746,000 | $760,000 | $493,000 | $585,000 |
| Increase (Decrease) in Earnest Money Deposits Outstanding | $5,322 | $5,695 | $-7,099 | $-9,782 |
| Increase (Decrease) in Other Operating Assets | $-23,033 | $-3,851 | $-60,420 | $-15,124 |
| Increase (Decrease) in Accounts Payable | $6,330 | $1,655 | $-17,092 | $12,706 |
| Payments of Debt Issuance Costs | $14,322 | $5,982 | $5,641 | $1,985 |
| Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities | $-18,256 | $14,126 | $-18,843 | $6,861 |
| Proceeds from Issuance of Common Stock | $5,260 | $4,831 | $3,607 | $3,765 |
| Payments for Repurchase of Common Stock | $0 | $30,974 | $23,639 | $20,588 |
| Net Cash Provided by (Used in) Financing Activities | $87,596 | $132,338 | $120,085 | $-182,426 |